In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Tagalakis, Aristides D.
Larsen, Scott D.
Neubig, Richard R.
Khaw, Peng T.
Lim, Kin Sheng
Funding for this research was provided by:
Medical Research Council (535333)
National Institute for Health Research
Moorfields Eye Charity